In this issue:
Phenotypic severity & medication/pharmacogenomic variables in schizophrenia
Different pharmacotherapies in treatment-resistant schizophrenia
Moral decision-making in schizophrenia
CBT for negative symptoms & function in schizophrenia
COaST: semaglutide in patients with schizophrenia & obesity on clozapine
STARLYNG: long-acting oral weekly risperidone (LYN-005) in schizophrenia
EEG features with refractory positive symptoms in schizophrenia
Cardiovascular disease/risk factors in schizophrenia
Predictors of remission in real-world patients receiving once-monthly aripiprazole
Cumulative incidence of schizophrenia in an Australia centre
Please login below to download this issue (PDF)